effect of tachycardia on lipid metabolism and expression of fatty acid
Transkrypt
effect of tachycardia on lipid metabolism and expression of fatty acid
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2015, 66, 5, 691-699 www.jpp.krakow.pl B. WOJCIK1,2, E. HARASIM1, P. ZABIELSKI1, A. CHABOWSKI1, J. GORSKI1,2 EFFECT OF TACHYCARDIA ON LIPID METABOLISM AND EXPRESSION OF FATTY ACID TRANSPORTERS IN HEART VENTRICLES OF THE RAT 1 Department of Physiology, Medical University of Bialystok, Bialystok, Poland; Medical Institute, Lomza State University for Applied Sciences, Lomza, Poland 2 Tachycardia increases oxidation of the plasma-borne long chain fatty acids in the heart. The aim of the present study was to examine effect of tachycardia on: 1) the total level of free fatty acids, diacylglycerols, triacylglycerols and phospholipids in both heart ventricles; 2) 14C-palmitate incorporation in the lipid fractions; 3) expression of fatty acid and glucose transporters in the ventricles. Tachycardia was induced in anesthetized rats by electrical atrial pacing at the rate of 600/min. Samples of the left (LV) and right (RV) ventricle were taken after 30 and 60 min pacing. The level free fatty acids, diacylglycerols, triacylglycerols and phospholipids was determined by means of gas-liquid chromatography and 14C-palmitate incorporation by liquid scintillation counting, respectively. Expression of fatty acid- and glucosetransporters was determined using Western blot technique. In LV, 30min pacing increased the content of diacylglycerols whereas the content of other lipids remained stable. After 60 min of pacing the levels of the examined lipid fractions did not differ from the respective control values. In RV, the content of diacylglycerols and triacylglycerols was reduced both after 30 and 60 min pacing. Tachycardia also affected incorporation of 14C-palmitate in lipid fractions of goth ventricles. 30 min pacing up-regulated plasmalemmal expression of FAT/CD36 (fatty acid translocase) in both ventricles and reduced its microsomal expression in LV. After 60 min pacing they did not differ from the respective control values. Plasmalemmal expression of FATP-1 (fatty acid transport protein 1) increased and its microsomal expression decreased in RV after 30 min pacing. After 60 min pacing the plasmalemmal FATP-1 expression remained elevated whereas the microsomal expression did not differ from the control value. Pacing did not affect or expression of FABPpm (plasma membrane associated fatty acid binding protein) in either plasma membranes and microsomal compartments. Thirty min pacing increased plasmalemmal and reduced microsomal expression of GLUT-4 (glucotransporter 4) in both ventricles. It increased plasmalemmal expression of GLUT-1 (glucotransporter 1) in RV. It returned to normal after 60 min pacing. It is concluded that tachycardia induces numerous changes in metabolism of myocardial lipids as well as expression of fatty acid and glucose transporters in both heart ventricles. K e y w o r d s : lipid metabolism, 14C-palmitate incorporation, fatty acid transporters, glucose transporters, tachycardia, heart ventricles, pacing, triacylglycerols INTRODUCTION Blood-borne long chain fatty acids cover an essential part of energy sources used by the heart (1). Their utilization increases during increased contractile activity of the heart in vivo (2) and in isolated cardiomyocytes (3). There are only very few data available on effect of tachycardia on endogenous heart lipid metabolism. The level of triacylglycerol in the left ventricle was found to be stable during 15 and 30 min atrial pacing in the rat (4). Luiken at al. (3) reported that 3 min electrostimulation of cardiomyocytes increased incorporation of 14C-palmitate in the fraction of triacylglycerols. It returned to normal values after 30 min stimulation. In the same settings, incorporation of the label in the fraction of phospholipids remained unchanged during stimulation (3). Recent data indicate that tachycardia produces changes in metabolism of bioactive sphingolipids in both ventricles of the rat (5). Such changes could have an important impact on the heart resistance to ischemia/reperfusion injury (6). We are not aware of other data regarding the effects of tachycardia on the level of lipid fractions in the myocardium. Also, it remains an open question whether tachycardia affects distribution of the plasma-borne long chain fatty acids in particular lipid fractions in the myocardium. Long chain free fatty acids are transported across the plasma membrane mostly with the assistance of fatty acid translocase (FAT/CD36), plasma membrane associated fatty acid binding protein (FABPpm) and fatty acid transport proteins (FATP1 and FATP6) (7, 8). Studies on isolated cardiomyocytes showed that contractile activity induced by electrical stimulation increases plasmalemmal content of FAT/CD36 (9, 10). As far, no data are available regarding an effect of in vivo tachycardia on behavior of the fatty acid transporters in myocardium. The aim of the present study was to examine effect of tachycardia on: 1) the total level of free fatty acids, diacylglycerols, triacylglycerols and phospholipids in the left and right heart ventricles; 2) incorporation of 14C-palmitate in the lipid fractions; 3) expression of fatty acid and glucose 692 transporters in the plasmalemmal and microsomal fractions of the both ventricles of the rat. Subcellular fractionation of cardiac myocytes The experimental protocol was approved by the Ethical Committee on the Animal Research at the Medical University of Bialystok. The experiments were carried out on male Wistar rats, 230 – 250 grams of body weight. The rats were housed in standard conditions: temperature 21°C, 12 h light/12 h dark cycle, had free access to tap water and commercially available rat pellet diet. The rats were anaesthetized with thiopental (80 mg/100 g of body weight). After anesthesia, the right jugular vein was exposed and two electrodes were inserted in it. The electrodes were located at the aperture of the vein. The location of the tips of the electrodes was checked after the experiment, to confirm proper positioning. The electrodes were connected to SC-04 stimulator. The heart rate was continuously monitored by ECG through electrodes administered into skeletal muscles of the four limbs. The resting heart rate after anesthesia was 366 ± 29/min. The rats were divided into four groups (n = 10 rats in each group): two control groups, with 30 and 60 min of anesthesia but no pacing, and two paced groups, subjected to heart stimulation for 30 and 60 min, respectively. The parameters of the stimuli were: frequency 600/min, 4V, duration 100 ms. To follow incorporation of the blood-borne free fatty acids in myocardial lipid fractions, albumin bound 14C-palmitate (Perkin Elmer, S.A. 561 µCi/mmol) was administered in the tail vein at a dose of 5 µCi/100 g of body weight at zero time. Blood from the abdominal aorta and samples of the right and left ventricle were taken. Isolation of plasma membranes (PM) and low density microsomes (LDM) from the left and right ventricle was performed by subcellular fractionation. Differential centrifugation was carried out as it was described previously with minor modifications (15-17). After thawing, ventricles were minced and incubated for 30 min in ice-cold high-salt solution (2 mol/l NaCl, 20 mmol/l HEPES pH 7.4, 5 mmol/l NaN3 and protease inhibitors). Thereafter, the suspension was centrifuged (5 min, 1000 g) and the pellet was homogenized in 6.0 ml TES-buffer (20 mmol/l Tris pH 7.4, 1 mmol/l EDTA, 250 mmol/l sucrose and protease inhibitors) using a tightly fitting 10-ml Potter-Elvehjem glass homogenizer with 10 strokes. Afterwards, the homogenate was spun (5 min, 1000 g) and the pellet was re-homogenized in 4.0 ml TES-buffer. The resulting homogenate was combined with the previous supernatant and centrifuged (10 min, 100 g). Obtained pellet (P1) was resuspended in 300 µl TES-buffer and saved. Subsequently, the supernatant was spun (10 min, 5000 g) and the pellet (P2) was resuspended in 300 µl TES-buffer and saved. The supernatant was centrifuged again (20 min, 20 000 g) and the pellet (P3) was resuspended in 300 µl TES-buffer and saved. Next, the supernatant was centrifuged (30 min, 48,000 g) and the pellet (P4) was resuspended in 150 µl TESbuffer and saved. After the last centrifugation of supernatant (65 min, 250,000 g), received pellet (P5) was resuspended in 150 µl TES-buffer and saved. It has been established upon analysis of P1-P5 pellets with ATPase sodium/potassium pump (Na+/K+) and glucose transporter 4 (GLUT-4) immunoblotting, that fractions P2 refers as PM- fraction and P5 as LDM fraction according to Fuller et al. (15). Measurement of the level of lipids Immunoblotting Samples of each ventricle were blotted dry and frozen in liquid nitrogen. Next, they were pulverized in an aluminum mortar precooled in liquid nitrogen. The powder was transferred into a glass tube containing methanol at a temperature of –20°C (11). Lipids were extracted according to Bligh and Dyer (12). They were separated into different fractions by means of thinlayer chromatography. Silica plates, 220 µm (Merck) and developing mixture composed of heptane, diisopropyl ether and acetic acid (60 : 40 : 3 v/v/v) was employed (13). The plates were dried, sprayed with 0.5% solution of 3’7’dichlorofloresceine in methanol, exposed briefly to ammonia vapors and visualized under an ultraviolet lamp. The procedure enabled localization of different lipid bands. Bands containing the fractions of free fatty acids (FFA), diacylglycerols (DG), triacylglycerols (TG) and phospholipids (PH) were scraped off and methylated (14). For plasma FFA, 100 µl of plasma was extracted and methylated using the same approach. The individual fatty acids of each fraction were identified and quantified by means of gas-liquid chromatography (HewlettPackard 5890 Series II gas chromatograph with Varian CPSIL88, capillary column (50 mm × 0.25 mm internal diameter) and flame-ionization detector (FID) (Agilent Technologies, CA, USA). Methylpentadecanoic acid (Aldrich) was used as an internal standard. Total FFA, DG, TG and PH content was estimated as a sum of the particular fatty acid species. For labeled palmitate lipid incorporation measurement the procedure of separation of the lipids was repeated using another muscle and plasma samples. The bands containing the above lipid fractions and plasma FFA were scraped off the plates into the scintillation vials, a scintillation cocktail (Ultima Gold, Packard) was added and the radioactivity was counted using Packard Tri-Carb 1900 LSC counter. Routine Western blotting procedure was used to assess the expression of fatty acids and glucose transporters in isolated PM and LDM fractions, as it was described in details previously (18). Protein concentration in each sample was determined by using the bicinchonic acid method (BCA) with bovine serum albumin (BSA) as a standard. Briefly, after SDSPAGE separation, transfer, and blocking the membranes were incubated overnight at 4°C with corresponding primary antibodies in appropriate dilutions i.e. FAT/CD36 (1:500; Abcam, UK), FABPpm (1:30000; a gift from Dr. CallesEscandon), FATP-1, Glut-1, Glut-4 (1:200; Santa Cruz Biotechnology, USA) and β-actin (1:1000; Sigma-Aldrich, USA). Thereafter, appropriate HRP-conjugated secondary antibody (1:3000; Santa Cruz Biotechnology, USA) was used to visualize blotted proteins. Signals obtained by immunoblotting were quantified densitometrically using a ChemiDoc XRS + visualization system and ImageLab software (Bio Rad, Hercules, CA, USA). Equal protein concentrations were loaded in each lane (25 µg) what was also confirmed by Ponceau S staining. Protein expression was standardized to βactin expression and the control group was set as 100%. Additionally, purity of isolated PM and LDM from the left and right ventricle was confirmed by measuring the expression of ATP-ase Na+/K+ (1:200; Santa Cruz Biotechnology, USA) and Glut-4 (1:200; Santa Cruz Biotechnology, USA) according to Fuller et al. (15). MATERIALS AND METHODS Statistical analysis Statistical significance for both the within ventricle and between ventricles comparisons was estimated by ANOVA with Tukey HSD post-hoc test, using Statistica 10 software package. 693 RESULTS min pacing increased incorporation of the label in each ventricle comparing to the respective 60 min controls (Fig. 2F). Free fatty acids Phospholipids Plasma FFA concentration was stable during pacing (Fig. 1A). The incorporation of 14C-palmitate in this fraction during pacing did not differ from the respective control value (Fig. 1B). The level of FFA fraction in the left ventricle was not affected by stimulation (Fig. 2A). In the right ventricle, it was stable after 30 min stimulation. Sixty min control level of the fraction in the right ventricle was higher than 30 min control level and it was reduced after 60 min stimulation (Fig. 2A). Incorporation of the label increased in both ventricles after 30 min pacing as compared to the respective controls. After 60 min stimulation the incorporation decreased as compared to the appropriate value after 30 min pacing. However, it was higher in each ventricle than the respective 60 min control (Fig. 2B). Diacylglycerols Thirty min pacing increased the content of diacylglycerols in the left ventricle and reduced it in the right one comparing to the appropriate control value. After 60 min pacing, the level of diacylglycerols in the left ventricle was lower than after 30 min but it remained on the same level in the right one. The control levels of diacylglycerols in the right ventricle were higher than in the left one. The level after 30 min pacing in the right ventricle was lower and after 60 min was higher from the corresponding value in the left ventricle (Fig. 2C). Pacing did not affect incorporation of the label in the left ventricle comparing to the respective controls. In the right ventricle, both 30 and 60 min pacing increased the label incorporation comparing to the respective values without pacing (Fig. 2D). Triacylglycerols Pacing did not affect the level of triacylglycerols in the left ventricle. In the right ventricle, it was reduced after 30 min pacing and remained further stable. The control levels in the right ventricle were higher than in the left one (Fig. 2E). Thirty min pacing did not affect the incorporation of the label in the left ventricle and elevated it in the right one. Sixty The level of phospholipids in each ventricle remained stable during pacing. There were no differences in the level of phospholipids between the ventricles (Fig. 2G). Thirty min pacing increased incorporation of the label in both ventricles. It did not differ from the respective control in either ventricle after 60 min pacing (Fig. 2H). Expression of fatty acid transporters Fatty acid translocase (FAT/CD36) Thirty min pacing increased expression of the plasmalemmal fraction of FAT/CD36 in both ventricles. It returned to basal levels after 60 min pacing. Expression of the microsomal fraction of the protein decreased after 30 min pacing in the left ventricle and normalized after 60 min pacing. Plasma membrane associated fatty acid binding protein (FABPpm) Sixty min pacing increased expression of the plasmalemmal fraction of the protein in the left ventricle as compared to 60 min control. Fatty acid transport protein 1 (FATP-1) Thirty min pacing increased expression of the plasmalemmal fraction and reduced expression of the microsomal fraction of the protein in the right ventricle. After 60 min pacing, expression of the plasmalemmal fraction of the protein remained elevated in the ventricle. Expression of glucose transporters Glucotransporter 4 (GLUT-4) Thirty min pacing elevated expression of the plasmalemmal fraction of protein and reduced expression of its microsomal Fig. 1. Impact of atrial pacing on plasma fatty acids content (panel A) and 14C-palmitate incorporation (panel B) after 30 minutes and 60 minutes of stimulation. To measure plasma FFA content and 14C-palmitate incorporation we used 100 ml of the plasma sample and the same approach as for the tissue lipid fractions. Values are mean ± S.E.M., n = 8 per group, cP < 0.05 60min vs. 30 min of stimulation. 694 Fig. 2. Impact of atrial pacing on left and right ventricle content and 14C-palmitate incorporation of free fatty acids (FFA; panel A, B), diacylglycerols (DG; panel C, D), triacylglycerols (TG; panel E, F) and phospholipids (PH; panel G, H) after 30 minutes and 60 minutes of stimulation. Values are mean ± S.E.M., n = 8 per group. aP < 0.05 pacing vs. control (within ventricle type); bP < 0.05 right vs. left ventricle (within stimulation duration); cP < 0.05 60min vs. 30 min of stimulation (within ventricle type). 695 Fig. 3. Effect of atrial pacing on plasmalemmal (A) and microsomal (B) expression of FAT/CD36 in the left and right ventricle. The data are expressed as the mean ± S.E.M. and are based on six independent determinations (n = 6). aP < 0.05 control vs. pacing (within ventricle type) and cP < 0.05 pacing 60 min vs. pacing 30 min of stimulation duration (within ventricle type). Fig. 4. Effect of atrial pacing on plasmalemmal (A) and microsomal (B) expression of FABPpm in the left and right ventricle. The data are expressed as the mean ± S.E.M. and are based on six independent determinations (n = 6). aP < 0.05 control vs. pacing (within ventricle type) and cP < 0.05 pacing 60 min vs. pacing 30 min of stimulation duration (within ventricle type). 696 Fig. 5. Effect of atrial pacing on plasmalemmal (A) and microsomal (B) expression of FATP1 in the left and right ventricle. The data are expressed as the mean ± S.E.M. and are based on six independent determinations (n = 6). aP < 0.05 control vs. pacing (within ventricle type) and cP < 0.05 pacing 60 min vs. pacing 30 min of stimulation duration (within ventricle type). Fig. 6. Effect of atrial pacing on plasmalemmal (A) and microsomal (B) expression of GLUT-4 in the left and right ventricle. The data are expressed as the mean ± S.E.M. and are based on six independent determinations (n = 6). aP < 0.05 control vs. pacing (within ventricle type) and cP < 0.05 pacing 60 min vs. pacing 30 min of stimulation duration (within ventricle type). 697 Fig. 7. Effect of atrial pacing on plasmalemmal (A) and microsomal (B) expression of GLUT-1 in the left and right ventricle. The data are expressed as the mean ± S.E.M. and are based on six independent determinations (n = 6). aP < 0.05 control vs. pacing (within ventricle type) and cP < 0.05 pacing 60 min vs. pacing 30 min of stimulation duration (within ventricle type). fraction in both ventricles. The expression was normalized after 60 min pacing. Glucotransporter 1 (GLUT-1) Thirty min pacing increased expression of the plasmalemmal fraction of the protein in the right ventricle. It normalized after 60 min pacing. DISCUSSION The control levels of phospholipids, di- and triacylglycerols in the left ventricle are similar to the levels previously reported whereas the level of free fatty acids is higher than the previous one (19). However, in the present study, the control rats underwent surgery and it could result in mobilization of the latter compound. The results obtained herein, show that the effect of pacing on the heart lipid metabolism depends on time of pacing, ventricle and examined lipid fraction. Regarding the left ventricle, pacing elevated only transiently the level of diacylglycerols and the levels of other fractions remained stable during stimulation. The data concerning triacylglycerols in the left ventricle are in agreement with previously reported results (4). Interestingly, 30 min pacing reduced the level of diacylglycerols and triacylglycerols in the right ventricle. It took place in spite of increased incorporation of the label in the two fractions. It would indicate that both di- and triacylglycerols are utilized during pacing and that the rate of their utilization exceeds the rate of re-synthesis. A mechanism responsible for mobilization of triacylglycerols only in the right ventricle remains uncertain. It is likely that tachycardia puts relatively greater burden on the right ventricle than on the left one. As a result, more endogenous energy sources had to be used in the right than the left ventricle. Contractile activity affects incorporation of the blood-borne free fatty acids in different lipid fractions in skeletal muscles (20). As mentioned in the introduction, electrical stimulation of isolated cardiomyocytes increased transiently incorporation of the label in triacylglycerol but not in phospholipid fraction. The present data show that increased work output during tachycardia induces incorporation of 14C-palmitate in each examined lipid fraction in the right ventricle and depending on time, in each fraction, with the exception for diacylglycerols, in the left ventricle. It indicates that tachycardia increases turnover of fatty acids in different lipid fractions in both ventricles. Muscular exercise was shown to induce a number of changes in the content and composition of fatty acids in different lipid fractions in the left heart ventricle of the rat (21). The present results would suggest that exercise induced tachycardia could be responsible for the above changes. As indicated in the Introduction, long chain free fatty acids enter cardiomyocytes mostly via protein-mediated transport facilitated by fatty acid transporters (7, 8). The transporters translocate to the plasma membrane upon stimulation of the isolated cardiomyocytes. As a result, expression of the transporters in the plasma membrane increases at the expense of the expression in the microsomal fraction (9, 10). Therefore, we studied the expression of the transporters in both cellular compartments (plasma membrane as well as low density microsomes) in both ventricles during tachycardia in vivo. The results obtained clearly indicate that tachycardia induces the 698 process of translocation of FAT/CD36 to the plasma membrane in either ventricle. FAT/CD36 is the major transporter of long chain fatty acids across the plasma membrane. Elevation in its plasmalemmal expression in the ventricles during pacing would correspond with the data indicating increased utilization of the fatty acids by myocardium during tachycardia (22). In the right ventricle, the transport of fatty acids was additionally, supported by increased plasmalemmal expression of FATP-1 during the first 30 min of tachycardia, which also corresponds to increased utilization of long chain fatty acids, as indicated by increased incorporation of 14C-palmitate in each examined lipid fraction. Increased contractile activity induces translocation both FAT/CD36 and GLUT-4 in isolated cardiomyocytes (23, 24). We investigated whether in vivo tachycardia also induces changes in the expression of glucotransporters. And, we showed that in case of GLUT-4, the principal glucose transporter in myocardium, tachycardia induces elevation in its expression in the plasma membrane and reduces expression in microsomes in both ventricles. These data are also in line with the reports indicating increased utilization of glucose by myocardium during tachycardia (22, 25). Reports on metabolic differences between the left and right heart ventricle are very scarce. The level of glycogen and triacylglycerols was previously shown to be similar in both ventricles. Additionally, the degree of exercise-induced reduction in the level of glycogen was similar (4). El Alwani et al. reported lower level of ceramide in the right ventricle than in the left one (26). Other differences in metabolism of selected sphingolipids between the ventricles were also reported (5). According to Broderick and King, the control level of GLUT4 in the both ventricles was similar (27) and we confirmed it presently. We also showed elevation in the plasmalemmal expression of GLUT-1, but only in the right ventricle after 30 min pacing. Our contribution provides data indicating the existence of several differences in metabolism of lipids and expression of FATP-1 and FAT/CD36 between the two ventricles during tachycardia. So far, the physiological meaning of the differences in metabolism between the two ventricles remains obscure. It is concluded that tachycardia induces numerous changes in metabolism of endogenous lipids as well expression of fatty acid and glucose transporters in both heart ventricles. Observed changes depended on either lipid fraction, type of transporter, time of pacing and location (left and right ventricle). Abbreviations: DG, diacylglycerols; FABPpm, plasma membrane associated fatty acid binding protein; FAT/CD36, fatty acid translocase; FATP1 and FATP6, fatty acid transport proteins 1 and 6; FFA, free fatty acids; GLUT1 and GLUT4, glucotransporter 1 and 4; LV, left ventricle; PH, phospholipids; RV, right ventricle; TG, triacylglycerols; Acknowledgements: This work was supported by the Medical University of Bialystok, grants nr N/ST/ZB/15/006/1118 and N/ST/ZB/15/003/1118. Conflict of interest. None declared. REFERENCES 1. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010; 90: 207-258. 2. Bergman BC, Tsvetkova T, Lowes B, Wolfel EE. Myocardial FFA metabolism during rest and atrial pacing in humans. Am J Physiol Endocrinol Metab 2009; 296: E358-E366. 3. Luiken JJ, Willems J, van der Vusse GJ, Glatz JF. Electrostimulation enhances FAT/CD36-mediated longchain fatty acid uptake by isolated rat cardiac myocytes. Am J Physiol Endocrinol Metab 2001; 281: E704-E712. 4. Bockowski L, Wojcik B, Budlewska M, Gorski J. Glycogen and triacylglycerols levels in the rat heart ventricles during tachycardia. Kardiol Pol 1994; 40: 299-302. 5. Wojcik B, Baranowski M, Chabowski A, Gorski J. Effect of atrial pacing on the level of bioactive sphingolipids in the heart ventricles of the rat. J Physiol Pharmacol 2015; 66: 385-389. 6. Knapp M. Cardioprotective role of sphingosine-1phosphate. J Physiol Pharmacol 2011; 62: 601-607. 7. Chabowski A, Gorski J, Glatz JF, Luiken JJ, Bonen A. Protein-mediated fatty acid uptake in the heart. Curr Cardiol Rev 2008; 4: 12-21. 8. Schwenk RW, Luiken JJ, Bonen A, Glatz JF. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res 2008; 79: 249-258. 9. Bonen A, Luiken JJ, Arugum Y, Glatz JFC, Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 2000; 275: 14501-14508. 10. Luiken JJ, Coort SL, Williams J, et al. Contraction-induced fatty acid translocase.CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003; 52: 1627-1634. 11. Veerkamp JH, Van Moerkerk HT, Van den Born J. No correlation between changes in fatty acid-binding protein content and fatty acid oxidation capacity of rat tissues in experimental diabetes. Int J Biochem Cell Biol 1996; 28: 473-478. 12. Bligh EG, Dryer WJ. A rapid method of total lipid extraction and purification. Can J Biochem 1959; 37: 914-917. 13. Conquer J, Mahadevappa VG. Evidence for the possible involvement of protein kinase C in the activation of nonspecific phospholipase A2 in human neutrophils. J Lipid Mediat 1991; 3: 113-123. 14. Morrisson WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoridemethanol. J Lipid Res 1964; 5: 600-608. 15. Fuller W, Eaton P, Medina RA, Bell J, Shattock MJ. Differential centrifugation separates cardiac sarcolemmal and endosomal membranes from Langendorff-perfused rat hearts. Anal Biochem 2001; 293: 216-223. 16. Luiken JJ, Koonen DP, Willems J, et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 2002; 51: 3113-3119. 17. Kalinowska A, Gorski J, Harasim E, Harasiuk D, Bonen A, Chabowski A. Differential effects of chronic, in vivo, PPAR’s stimulation on the myocardial subcellular redistribution of FAT/CD36 and FABPpm. FEBS Lett 2009; 583: 2527-2534. 18. Chabowski A, Zendzian-Piotrowska M, Konstantynowicz K, et al. Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes. Acta Physiol (Oxf) 2013; 207: 346-357. 19. Baranowski M, Blachnio-Zabielska A, Gorski J. Peroxisome proliferator-activated receptor activation induces unfavourable changes in fatty acid composition of myocardial phospholipids. J Physiol Pharmacol 2009; 60: 13-20. 20. Gorski J, Bonen A. Palmitate incorporation into lipids pools of contracting red and white muscles. Mol Cell Biochem 1997; 166: 73-83. 21. Wojcik B, Nawrocki A, Chocian G, Gorski J. Effect of exercise on fatty acid content in the rat heart. Biol Sport 1999; 16: 87-89. 699 22. Bergman BC, Tsvetkova T, Lowes B, Wolfel EE. Myocardial glucose and lactate metabolism during rest and atrial pacing in humans. J Physiol 2009; 587: 2087-2099. 23. Luiken JJ, Coort SL, Koonen DP, Bonen A, Glatz JF. Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes. Proc Nutr Soc 2004; 63: 251-258. 24. Steinbusch LK, Schwenk RW, Ouwens DM, Diamant M, Glatz JF, Luiken, JJ. Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes. Cell Mol Life Sci 2011; 68: 2525-2538. 25. Camici P, Marraccini P, Marzilli M, et al. Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. Am J Physiol 1989; 257: E309-E317. 26. El Alwani M, Usta J, Nemer G, et al. Regulation of the sphingolipid signaling pathways in the growing and hypoxic rat heart. Prostaglandins Other Lipid Mediat 2005; 78: 249-263. 27. Broderick TL, King TM. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension. Med Sci Monit 2008; 14: BR262-BR264. R e c e i v e d : March 19, 2015 A c c e p t e d : July 22, 2015 Author’s address: Prof. Jan Gorski, Department of Physiology, Medical University of Bialystok, 1 Kilinskiego Street, 15-089 Bialystok, Poland. E-mail: [email protected]